Genetics
Making genomic complexity accessible to everyone
Every genome is unique.
Precision begins here.
Genetics shapes health across the whole lifespan, and identifying genetic variants provides healthcare professionals with essential information to support prevention, monitoring and management strategies. Access to testing, however, remains uneven across regions and healthcare settings. Simple, standardized and fast technologies help close that gap, enabling every laboratory to generate consistent, reliable genomic data.
Clarity and consistency
From sample to result, simple and standardized procedures, at the bench and in data analysis, reduce variability and turn complex genomic data into clear, consistent information that professionals can interpret with confidence.
Scalability
Testing needs differ across laboratories and evolve over time. Solutions that scale from focused to comprehensive analyses help laboratories expand their offering without rebuilding their processes.
Family awareness
The value of genetic information extends beyond the individual: identifying an inherited variant can guide testing in relatives, helping families understand shared risk and make informed health decisions.
Myriapod® NGS
The complete NGS solution for hereditary cancer genetics
Myriapod® NGS is the scalable, easy-to-use portfolio for hereditary cancer genetics, delivering clear, consistent results from focused to comprehensive panels—supporting the democratization of genetic testing.
Comprehensive
Easy & Fast
Regulatory
Meeting the needs of any lab, advancing care for patients
The Myriapod® NGS portfolio for hereditary cancer genetics is designed to make hereditary cancer testing more accessible: a simple, standardised workflow that scales with your laboratory’s needs – from focused to comprehensive panels – supported by the same streamlined data analysis solution. Thanks to its scalability and minimal hands-on time, Myriapod® NGS helps deliver consistent, high-quality results, in every lab, at every step, everywhere.
Myriapod NGS Dry
Myriapod NGS Automation
BRCA 1-2
2
genes
Full CDS coverage
Teste biomarkers
SNVs · InDels · CNVs
Myriapod® NGS
BRCa Plus
20
genes
Full CDS coverage
Teste biomarkers
SNVs · InDels · CNVs
Myriapod® NGS
Hereditary
40
genes
Full CDS coverage
Teste biomarkers
SNVs · InDels · CNVs
Myriapod NGS Dry
Myriapod NGS Automation
Simple
ready-to-use
reagent format
Sample flexibility
optimised for whole blood, FFPE, fresh tissue and other sample types
Regulatory
complies with Regulatory (EU) 2017/746 (IVDR) where applicable
Fast TAT
from sample to results in <4 days
On-premise
data analysis